Why the study?
The study aimed to evaluate the incremental prognostic value of ischemic score quantified by stress dynamic CT-MPI in patients with and without diabetes mellitus.
Does ischemic perfusion defect quantified by stress dynamic CT-MPI provide incremental prognostic value for predicting MACE in patients with suspected CAD, with and without diabetes mellitus?
Does ischemic perfusion defect quantified by stress dynamic CT-MPI provide incremental prognostic value for predicting MACE in patients with suspected CAD, with and without diabetes mellitus?
Ischemic perfusion defects quantified by stress dynamic CT-MPI provide significant incremental prognostic value beyond traditional clinical risk factors and CCTA anatomical parameters for predicting MACE in patients with and without diabetes.
Answers are grounded in this paper and cite their sources.
Ischemic score from CT-MPI may refine MACE risk stratification in suspected CAD with or without DM; hypothesis-generating pending prospective validation.
This study aimed to assess the incremental prognostic value of ischemic score quantified by stress dynamic CT myocardial perfusion imaging (CT-MPI) in patients with and without diabetes mellitus (DM). 331 patients (92 patients with DM) with suspected coronary artery disease (CAD) who underwent coronary computed tomography angiography (CCTA) and CT-MPI were included. Major adverse cardiovascular events (MACE) included cardiac death, acute coronary syndrome (ACS), late revascularization, and hospitalizations attributable to heart failure. Ischemic score was assessed based on reduced myocardial blood flow across 16 segments. An ischemic perfusion defect (IPD) was identified as ischemic score ≥ 4. During a median follow-up of 15 (9, 40) months, 49 patients (14.8%) experienced MACE. IPD was an independent predictor for the development of MACE in both DM (HR: 11.64, p = 0.019) and non-DM patient groups (HR: 8.66, p = 0.004). Adding IPD to clinical risk factors and CCTA characteristics increased the C-index for predicting MACE from 0.72 to 0.80 in DM patients (p = 0.005) and from 0.76 to 0.83 in non-DM patients (p = 0.006). IPD quantified by stress dynamic CT-MPI had incremental prognostic value over traditional clinical risk factors and anatomic parameters in both DM and non-DM patients.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: